SWHR announced the election of two new members to its Board of Directors: Gretta Stone, Deputy Vice President of Policy & Research at PhRMA and Dawn Halkuff, Chief Commercial Officer at TherapeuticsMD.
There are undoubtedly different sets of Alzheimer's disease risk factors that impact women versus men and these factors are likely to exert changes at different points in the lifespan.
When women think about menopause, they typically think about hot flashes. New research shows that memory problems are a common but under-recognized menopausal symptom.
In the U.S., more than four in ten women are obese, compared to a little more than a third of men.
SWHR is deeply concerned and discouraged to see that the Administration has deprioritized research and development in the 2018 budget through substantial decreases for critical federal agencies, expressed Dr. Amy M. Miller, SWHR president and CEO.
This guest blog by Judette Louis MD, MPH from University of South Florida and SWHR Interdisciplinary Network on Sleep Member and Mary Ashley Cain MD from University of South Florida explores the overlaps of sleep and pregnancy.
Distinguished physician and health policy expert, Dr. Scott Gottlieb, has been confirmed by the Senate as the next Food and Drug Administration (FDA) Commissioner. President Donald Trump nominated him in March 2017.
The Senate Committee on Health, Education, Labor, and Pensions (HELP Committee) recently voted in favor of Dr. Scott Gottlieb to be the next commissioner of the FDA.
This guest blog by Amita Sehgal, PhD from University of Pennsylvania and SWHR Interdisciplinary Network on Sleep Member and Paula Haynes, PhD from University of Pennsylvania explores circadian disorders.